NMI expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.219200E-01
Normal-vs-Stage2
7.197600E-01
Normal-vs-Stage3
1.819180E-01
Normal-vs-Stage4
3.828400E-01
Stage1-vs-Stage2
1.766850E-01
Stage1-vs-Stage3
9.740400E-01
Stage1-vs-Stage4
6.306600E-01
Stage2-vs-Stage3
2.493200E-01
Stage2-vs-Stage4
5.927200E-01
Stage3-vs-Stage4
6.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.735200E-01
Normal-vs-AfricanAmerican
1.496600E-01
Normal-vs-Asian
7.368200E-01
Caucasian-vs-AfricanAmerican
4.562000E-01
Caucasian-vs-Asian
5.796600E-01
AfricanAmerican-vs-Asian
4.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.075800E-01
Normal-vs-Female
5.447200E-01
Male-vs-Female
8.449800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.582400E-01
Normal-vs-Age(41-60Yrs)
7.017400E-01
Normal-vs-Age(61-80Yrs)
5.289200E-01
Normal-vs-Age(81-100Yrs)
3.775600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.736800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.646600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.321400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.292200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.185200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.690200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.725400E-01
Normal-vs-Daily Drinker
7.866400E-01
Normal-vs-Weekly Drinker
3.071400E-01
Normal-vs-Occasional Drinker
6.989600E-01
Normal-vs-Social Drinker
7.874800E-01
Non Drinker-vs-Daily Drinker
2.583200E-01
Non Drinker-vs-Weekly Drinker
7.100200E-01
Non Drinker-vs-Occasional Drinker
3.428600E-01
Non Drinker-vs-Social Drinker
3.052200E-01
Daily Drinker-vs-Weekly Drinker
2.258000E-01
Daily Drinker-vs-Occasional Drinker
8.781200E-01
Daily Drinker-vs-Social Drinker
9.984800E-01
Weekly Drinker-vs-Occasional Drinker
2.706400E-01
Weekly Drinker-vs-Social Drinker
2.579600E-01
Occasional Drinker-vs-Social Drinker
8.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.624000E-01
Normal-vs-Grade 2
8.143700E-02
Normal-vs-Grade 3
7.698100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.194900E-04
Grade 1-vs-Grade 3
1.245260E-04
Grade 1-vs-Grade 4
5.624000E-01
Grade 2-vs-Grade 3
2.132200E-01
Grade 2-vs-Grade 4
8.143700E-02
Grade 3-vs-Grade 4
7.698100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.558800E-01
Normal-vs-NonDiabetic
6.145200E-01
Diabetic-vs-NonDiabetic
3.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.295200E-01
Normal-vs-NoPancreatitis
5.705400E-01
Pancreatitis-vs-NoPancreatitis
8.980200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.027200E-01
Normal-vs-N1
7.709000E-01
N0-vs-N1
7.238700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.320800E-01
Normal-vs-TP53-NonMutant
2.668400E-01
TP53-Mutant-vs-TP53-NonMutant
1.41410000376041E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
